Crispr Therapeutics shares owned by Banque Cantonale Vaudoise
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Banque Cantonale Vaudoise
from 13F filings
Historical chart of Banque Cantonale Vaudoise investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Banque Cantonale Vaudoise consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Banque Cantonale Vaudoise
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $803k | 17k | 46.94 |
2024-06-30 | $939k | 17k | 54.02 |
2024-03-31 | $1.1M | 17k | 68.22 |
2023-12-31 | $1.0M | 16k | 62.59 |
2023-09-30 | $736k | 16k | 45.42 |
2023-06-30 | $918k | 16k | 56.07 |
2023-03-31 | $710k | 16k | 45.30 |
2022-12-31 | $641k | 16k | 40.63 |
2022-09-30 | $1.0M | 16k | 65.42 |
2022-06-30 | $964k | 16k | 60.81 |
2022-03-31 | $266k | 4.2k | 62.90 |
2021-12-31 | $261k | 3.4k | 75.81 |
2021-09-30 | $455k | 4.1k | 111.90 |
2021-06-30 | $706k | 4.4k | 161.82 |
2021-03-31 | $575k | 4.7k | 121.74 |
2020-12-31 | $1.6M | 10k | 153.18 |
2020-09-30 | $751k | 9.0k | 83.70 |
2020-06-30 | $637k | 8.7k | 73.52 |
2020-03-31 | $332k | 7.8k | 42.40 |
2019-12-31 | $523k | 8.6k | 60.89 |